Kingworld Medicines Group (HKSE:01110) Long-Term Capital Lease Obligation : HK$6 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group Long-Term Capital Lease Obligation?

Kingworld Medicines Group's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$6 Mil.

Kingworld Medicines Group's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (HK$13 Mil) to Jun. 2023 (HK$11 Mil) and declined from Jun. 2023 (HK$11 Mil) to Dec. 2023 (HK$6 Mil).

Kingworld Medicines Group's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (HK$2 Mil) to Dec. 2022 (HK$13 Mil) but then declined from Dec. 2022 (HK$13 Mil) to Dec. 2023 (HK$6 Mil).

Kingworld Medicines Group Long-Term Capital Lease Obligation Historical Data

The historical data trend for Kingworld Medicines Group's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group Long-Term Capital Lease Obligation Chart

Kingworld Medicines Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

9.32

1.47

1.78

12.71

6.49

Kingworld Medicines Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.78	1.84	12.71	11.17	6.49

Kingworld Medicines Group (HKSE:01110) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Kingworld Medicines Group Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kingworld Medicines Group (HKSE:01110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016

Website

https://www.kingworld.com.cn

Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Executives

Chan Lok San	2101 Beneficial owner
Zhao Li Sheng	2101 Beneficial owner
Sinopharm Capital Limited	2201 Interest of corporation controlled by you
Sinopharm Healthcare Fund L.p.	2101 Beneficial owner
Sun Hill Capital Investments Limited	2201 Interest of corporation controlled by you
Wu Aimin	2201 Interest of corporation controlled by you
Sun Hill Capital Investments Limited	2201 Interest of corporation controlled by you
Wu Aimin	2201 Interest of corporation controlled by you

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines